LIFE · Categories · Form 4
LIFE - SEC Form 4 insider transactions
Ethos Technologies Inc. (LIFE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for LIFE
- President Wang Lingke sold $1,024,561 worth of shares (46,349 units at $22.11), decreasing direct ownership by 14% to 695,302 units (SEC Form 4) (withholding tax)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- CEO and Secretary Colis Peter George sold $1,324,783 worth of shares (60,035 units at $22.07), decreasing direct ownership by 14% to 695,302 units (SEC Form 4) to satisfy withholding obligation4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Chief Financial Officer Capozzi Christopher M. was granted 80,287 shares and sold $1,783,698 worth of shares (80,586 units at $22.13), decreasing direct ownership by 0.04% to 665,228 units (SEC Form 4) (tax liability)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Chief Accounting Officer Kucharski Brandt Walter sold $128,435 worth of shares (5,823 units at $22.06) and was granted 56,769 shares, increasing direct ownership by 38% to 183,430 units (SEC Form 4) (for tax liability)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Large owner Gv 2019 Gp, L.L.C. disposed of 147,552 shares and sold $3,459,809 worth of shares (147,552 units at $23.45) (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Large owner Softbank Group Corp. converted options into 2,697,089 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Large owner Accel Growth Fund Iv L.P. converted options into 7,143,886 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Large owner Sc Us (Ttgp), Ltd. returned 12,000,124 shares to the company and converted options into 12,000,124 shares (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Large owner Sc Us (Ttgp), Ltd. converted options into 12,000,124 shares and returned 12,000,124 shares to the company (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Chief Technology Officer Sharma Vipul covered exercise/tax liability with 212,132 shares and sold $3,572,000 worth of shares (200,000 units at $17.86), decreasing direct ownership by 44% to 529,217 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Chief Accounting Officer Kucharski Brandt Walter covered exercise/tax liability with 53,237 shares and sold $221,964 worth of shares (12,428 units at $17.86), decreasing direct ownership by 33% to 132,484 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- CEO and Secretary Colis Peter George covered exercise/tax liability with 562,993 shares, decreasing direct ownership by 89% to 811,183 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- Chief Revenue Officer Lantz Erin N exercised 85,244 shares at a strike of $2.98, covered exercise/tax liability with 64,787 shares and sold $2,905,411 worth of shares (162,677 units at $17.86), decreasing direct ownership by 36% to 253,904 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- President Wang Lingke covered exercise/tax liability with 410,726 shares, decreasing direct ownership by 84% to 811,183 units (SEC Form 4)4 - Ethos Technologies Inc. (0001788451) (Issuer)
- SEC Form 4 filed by Clarke John K4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Gross Jane A4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Lucas Svetlana4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Schimmel Paul4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Zaknoen Sara4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Coughlin Timothy4 - aTYR PHARMA INC (0001339970) (Issuer)
- Shukla Sanjay converted options into 10,375 shares, increasing direct ownership by 10% to 116,548 units (SEC Form 4)4 - aTYR PHARMA INC (0001339970) (Issuer)
- Broadfoot Jill Marie converted options into 3,750 shares and sold $2,687 worth of shares (1,590 units at $1.69), increasing direct ownership by 12% to 20,821 units (SEC Form 4)4 - aTYR PHARMA INC (0001339970) (Issuer)
- Denyes Nancy converted options into 2,688 shares, increasing direct ownership by 22% to 14,767 units (SEC Form 4)4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Shukla Sanjay4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Broadfoot Jill Marie4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Denyes Nancy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Shukla Sanjay bought $30,224 worth of shares (15,000 units at $2.01), increasing direct ownership by 25% to 76,173 units4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Zaknoen Sara4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Schimmel Paul4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Lucas Svetlana4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Gross Jane A4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Coughlin Timothy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Clarke John K4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Schimmel Paul4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Schimmel Paul4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Coughlin Timothy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Lucas Svetlana4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Zaknoen Sara4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Gross Jane A4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Shukla Sanjay4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Broadfoot Jill Marie4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Denyes Nancy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Denyes Nancy converted options into 2,688 shares, increasing direct ownership by 61% to 7,079 units4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Broadfoot Jill Marie sold $3,696 worth of shares (1,566 units at $2.36) and converted options into 3,750 shares, increasing direct ownership by 16% to 15,460 units (for tax liability)4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Shukla Sanjay converted options into 10,375 shares, increasing direct ownership by 20% to 61,173 units4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Shukla Sanjay bought $21,405 worth of shares (10,000 units at $2.14), increasing direct ownership by 25% to 50,798 units4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Shukla Sanjay bought $43,164 worth of shares (15,000 units at $2.88), increasing direct ownership by 58% to 40,798 units4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Denyes Nancy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Broadfoot Jill Marie4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Shukla Sanjay4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Zaknoen Sara4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Schimmel Paul4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Lucas Svetlana4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Gross Jane A4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Coughlin Timothy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Clarke John K4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Denyes Nancy4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Broadfoot Jill Marie4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4 filed by Shukla Sanjay4 - aTYR PHARMA INC (0001339970) (Issuer)
- SEC Form 4: Broadfoot Jill Marie bought $12,980 worth of shares (1,923 units at $6.75), increasing direct ownership by 19% to 12,112 units4 - aTYR PHARMA INC (0001339970) (Issuer)